These results not only establish the pivotal role of the autophagy pathway in CDK4 turnover but also suggest the potential application of BEZ235 or other drugs via the therapeutic modulation of autophagic degradation of CDK4 protein in NB. Here, CDK4 is linked to neuroblastoma.